HS-10509
/ Jiangsu Hansoh Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 12, 2024
The Phase I Study of HS-10509 in Chinese Adult Subjects
(clinicaltrials.gov)
- P1 | N=80 | Not yet recruiting | Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
New P1 trial • CNS Disorders • Psychiatry • Schizophrenia • PRL
1 to 1
Of
1
Go to page
1